Published in Hepatitis Weekly, January 8th, 2001
Consequently, additional patients are now being enrolled in the second stage of the multi-center European Phase II trial. Omniferon is a multi-subtype alpha interferon derived from human white blood cells.
PPD Pharmaco, Inc., an independent Contract Research Organization (CRO), is executing Viragen's Phase II Clinical Trials in Europe to obtain objective data for submission to the regulatory authorities. The second stage of the Phase II trial will compare different dosing levels as compared to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly